0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA |

Highlights FREE

JAMA. 2015;314(23):2469-2471. doi:10.1001/jama.2014.12145.
Text Size: A A A
Published online

RESEARCH

The effect of red blood cell (RBC) storage duration on tissue oxygenation by transfused RBCs is uncertain. In a randomized, noninferiority trial involving 290 Ugandan children with lactic acidosis due to severe anemia, Dhabangi and colleagues found that transfusion of RBC units stored for 25 to 35 days compared with those stored for 1 to 10 days did not result in inferior reduction of elevated blood lactate levels—a surrogate of tissue oxygenation—assessed 8 hours after transfusion. In an Editorial, Spinella and Acker discuss the need for quality metrics to ensure the efficacy and safety of transfused RBCs.

Limited data suggest that autologous hematopoietic stem cell transplantation (HSCT) may benefit some patients with Crohn disease. In a parallel-group randomized trial involving 45 adult patients who had refractory Crohn disease not amenable to surgery and impaired quality of life despite treatment with 3 or more immunosuppressive biologic agents and corticosteroids, Hawkey and colleagues found that HCST was no different from conventional therapy in achieving sustained disease remission at 1 year and was associated with significant toxicity.

In a multicenter randomized trial involving 695 patients who had completed chemoradiotherapy for glioblastoma, Stupp and colleagues evaluated the safety and efficacy of tumor-treating fields (TTF)—transcutaneous delivery of low-intensity, intermediate-frequency alternating electric fields—used in combination with temozolomide maintenance treatment compared with temozolomide alone. In an interim analysis of 315 patients (median follow-up, 38 months), the authors found that adding TTF to maintenance temozolomide chemotherapy significantly prolonged progression-free and overall survival. In an Editorial, Sampson discusses alternating electric field therapy for the treatment of glioblastoma.

CLINICAL REVIEW & EDUCATION

Graves disease, an autoimmune thyroid disease caused by stimulating antibodies to the thyrotropin receptor on thyroid follicular cells, is the most common cause of persistent hyperthyroidism in adults. Based on a review and synthesis of data from 13 clinical trials, 5 systematic reviews, and 52 observational studies, Burch and Cooper provide an evidence-based update of the treatment of Graves disease. Optimal management depends on patient preference, geography, and clinical features. Treatment can include antithyroid drugs, destruction of the thyroid using radioiodine therapy, or thyroidectomy.

A 50-year-old man was evaluated for a 5-month history of blurry vision. He was not under regular medical care but reported that he had been diagnosed with the metabolic syndrome many years previously. He was not taking any medications. His body mass index was 30.6. His blood pressure was 160/102 mm Hg. A dilated retinal examination was performed. How would you interpret the findings?

This JAMA Diagnostic Test Interpretation article by Sam and Ehrmann presents the case of a 19-year-old woman seen for evaluation of oligomenorrhea—present since menarche. The patient expressed concern about acne and excessive facial hair, apparent thinning of her scalp hair, and a recent weight gain of 20 pounds. Physical examination revealed coarse dark hair on her chin and abdomen and acne on her face and back. Thyroid-stimulating hormone, prolactin, follicle-stimulating hormone, luteinizing hormone, and testosterone levels were obtained. How would you interpret these results?

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

3,145 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs